Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Comirnaty KP.2 adults and adolescents from 12 years COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials (Pfizer Ltd) |
| Virtual Medicinal Product | Generic Comirnaty KP.2 adults and adolescents from 12 years COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials |
| Name | Comirnaty KP.2 adults and adolescents from 12 years COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials |
| Abbreviated name | Comirnaty KP.2 COVID-19 Vacc 30microg/0.3ml dose inj md vial |
| Supplier | Pfizer Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✓ |
| Parallel import | ✗ |
| Restrictions on availability | Restricted Availability |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Comirnaty KP.2 adults and adolescents from 12 years COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials (Pfizer Ltd) 60 dose 10 x 6 dose vials | |
| Comirnaty KP.2 adults and adolescents from 12 years COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials (Pfizer Ltd) 6 dose | |
dm+d data retrieved from TRUD: release NHSBSA_2.2.0_20250217000001, imported on 18th February 2025 at 03:53:40.